Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 304 participants.

Also called NCT06190717

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 304 participants (planned count) (from the registry)
Sponsor
Sonavex, Inc. (from the registry)
Registry
  • NCT NCT06190717
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06190717. Randomized; no masking; primary purpose treatment. Start 2024-02-21 (actual); primary completion 2028-02-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
Acronym
MAFASA
Condition
Diabetes
Condition
End Stage Renal Disease
Intervention (Device)
EchoMark/EchoSure
Intervention (Procedure)
Standard of Care
Lead sponsor
Sonavex, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06190717
Content hash
42ff291aa871115fd966499b9101d53736bf37677117d7c0e0456181df8231f2